 PURPOSE: study compares cerebral protection using cerebroplegia using antegrade cerebroplegia variable flow rates deep hypothermic circulatory arrest (DHCA). METHODS: Twenty healthy neonatal piglets (2.5-3.8 kg) underwent 60 minutes DHCA. cerebroplegia used group 1 (n = 5). Cold (16 degrees C) antegrade cerebral perfusate administered innominate artery 10 mL/kg per minute group 2 (n = 5), 25 mL/kg per minute group 3 (n = 5), 50 mL/kg per minute group 4 (n = 5). Venous samples lactate, pyruvate, S-100B protein, creatine kinase BB (CKBB) drawn jugular vein discontinuation cardiopulmonary bypass--lactate 5 minutes postbypass, pyruvate 5 minutes postbypass, S-100B protein 30 minutes postbypass, CKBB 6 hours postbypass. Piglets killed 6 hours postbypass brains harvested histological/immunologic studies. Extent damage assessed using semiquantitative score 0 4 based validated method. RESULTS: Evidence significant apoptosis necrosis apparent groups. mean H&E score 2.2 group 1, 2.3 group 2, 2.5 group 3, 2.3 group 4. mean terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling score 1.0 group 1, 1.2 group 2, 1.7 group 3, 0.8 group 4. Pathological changes greater piglets antegrade cerebral perfusion. Serum lactate, pyruvate, S-100B protein, CKBB distinguish perfusion strategies. CONCLUSIONS: neonates, unmodified antegrade cerebral perfusion flow rates 10, 25, 50 mL/kg per minute DHCA provide additional protection brain determined histology, immunology, serum lactate, pyruvate, S-100B protein, CKBB.